Pfizer Inc.
ANTI-PD-1 ANTIBODY COMPOSITIONS
Last updated:
Abstract:
The present invention relates generally to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a high concentration antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by a formulation of an anti-PD-1 antibody.
Status:
Application
Type:
Utility
Filling date:
4 Mar 2019
Issue date:
7 Jan 2021